We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase Forward Announces FDA Contract Award for Production Rollout of WebSDM™ with Empirica™ Study

News   Nov 03, 2009

 
Phase Forward Announces FDA Contract Award for Production Rollout of WebSDM™ with Empirica™ Study
 
 
Advertisement
 

RELATED ARTICLES

Drug That Targets Challenging Cancer Mutation Could Treat Several Tumor Types

News

A new clinical trial shows a novel drug designed to counter the effects of an important cancer mutation could be effective against a range of tumor types including lung and gynecological cancers.

READ MORE

Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease

News

Researchers have deployed a machine learning model to help drug developers on their most promising leads for attacking one of the virus’ most compelling targets –SARS-CoV-2's main protease.

READ MORE

Avoiding Side Effects Associated With Cancer Treatment

News

Researchers at the University of California, Irvine and Switzerland's Lausanne University Hospital/University of Lausanne (CHUV/UNIL) may have found a way to treat cancer without the onset of debilitating side effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE